Analysts await PetMed Express, Inc. (NASDAQ:PETS) to report earnings on May, 09 for the fiscal quarter ending Mar 2016.

They expect $0.24 EPS, down 4.17% or $0.01 from last year’s $0.25 per share.

At the moment 5 analysts are watching PetMed Express, Inc. (NASDAQ:PETS), 0 rate it “Buy”, 0 “Outperform”, 3 “Underperform”, 2 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Sep-16, 3 analysts have a mean sales target of 57.06 million. For the quarter ending Dec-16, 3 analysts have a mean sales target of 50.88 million whilst for the year ending Mar-16, 5 analysts have a mean target of 229.52 million.

In terms of earnings per share, 3 analysts have a 0.23 EPS mean target for the quarter ending Sep-16, for the quarter ending Dec-16, 3 analysts have a 0.24 EPS mean target and for the quarter ending Dec-16 there are 5 estimates of 0.99 EPS.

The biggest institutional shareholders in PetMed Express, Inc. include Renaissance Technologies Corp which owns 2 million shares in the company valued at $29.21 million. BlackRock Fund Advisors is the second biggest holder with 1 million shares currently valued at 22.53 million whilst Vanguard Group Inc has 1 million shares valued at 18.70 million.

Total shares held by institutions as of the most recent company filings are 16,243,470 with a reported 989,854 bought and 1,196,319 sold. These holdings make up 80.24% of the company’s outstanding shares.

Currently insiders hold 2,487,720 shares in the business which makes up 12.24% of shares. The biggest holder currently is Mr. Guven Kivilcim who owns 1,264,100 shares (6.22% of those outstanding), whilst Mr. Menderes Akdag holds 620,000 (3.05% of shares outstanding) and Marc A. Puleo holds 363,286 (1.79% of shares outstanding).

The stock increased 4.46% or $0.8 during the last trading session.